21-04-2025
Vgenomics, Meril Genomics partner to improve access to genomic diagnostics in India
New Delhi: Precision health company
Vgenomics
announced their partnership with diagnostics and molecular biology provider
Meril Genomics
to provide complementary advanced
genomic diagnostics
to hospitals and research centers throughout India.
The partnership aims to enhance
precision medicine
accessibility. Initiatives under this partnership include
Non-Invasive Prenatal Testing
(NIPT), which addresses the growing risk of
chromosomal abnormalities
such as Down syndrome, especially among expectant mothers with advanced maternal age. NIPT will facilitate early detection, contributing to safer pregnancies and healthier newborn outcomes across India.
In addition, the collaboration introduces targeted Next-Generation Sequencing (tNGS) for Tuberculosis (TB), significantly impacting India's healthcare landscape, where roughly 26% of Global TB cases occur annually.
The initiative also includes Whole Exome Sequencing (WES) for diagnosing rare diseases, addressing the needs of approximately 70 million affected individuals in India.
Dr. Rahila Sardar, CEO of Vgenomics, said the collaboration reflects a shared commitment to making precision medicine available to more patients, more efficiently.
